Grants and Contributions:

Back to search

Title:

Canadian Life Sciences co-innovation mission to Japan – October 2025

Agreement Number:

1037489

Agreement Value:

$5,000.00

Agreement Date:

Sep 1, 2025 - Dec 3, 2025

Description:

BioAro is a Canadian AI-Biotech developing AI-guided Precision Medicine through multi-OMICS data analysis, including whole genome (WGS), exome (WES) & microbiome sequencing, cell-free DNA testing, epigenetics & transcriptomics. BioAro’s proprietary AI-driven analytics platform, PanOmiQ, processes this high-dimensional multi-OMICS data for actionable clinical output. These have helped commercialize the BioSport (high performance athletes), BioMYND (mental health) & Biogut (gut wellness & nutrition) programs. BioAro is currently focusing on Drug Development & Discovery, Drug Repurposing & Pharmacogenomics, including in-silico drug design & simulation of clinical trials. BioAro has also built a high performance computing centre

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Calgary, Alberta, CA T2P 0L4

Reference Number:

172-2025-2026-Q3-1037489

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

787849462

Recipient Type:

For-profit organization

Recipient's Operating Name:

BioAro Inc

Recipient's Legal Name:

BioAro Inc

Federal Riding Name:

Calgary Centre

Federal Riding Number:

48004

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

621510